IE 11 is not supported. For an optimal experience visit our site on another browser.

MAKO Surgical Corp. Schedules Third Quarter 2010 Earnings Release and Conference Call for Tuesday, November 2, 2010

FT. LAUDERDALE, Fla., Oct. 19, 2010 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release third quarter 2010 financial results after market close on Tuesday, November 2, 2010. Maurice R. Ferré, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will host a conference call to review the third quarter 2010 results starting at 4:30 pm EDT on the same day. The call will be concurrently webcast. 
/ Source: GlobeNewswire

FT. LAUDERDALE, Fla., Oct. 19, 2010 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release third quarter 2010 financial results after market close on Tuesday, November 2, 2010. Maurice R. Ferré, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will host a conference call to review the third quarter 2010 results starting at 4:30 pm EDT on the same day. The call will be concurrently webcast. 

To listen to the conference call please dial 877-843-0414 for domestic callers or 914-495-8580 for international callers and entering the passcode 16609765, approximately ten minutes prior to the start time. To access the live audio broadcast or the subsequent archived recording, visit the Investor Relations section of MAKO's website at . Following the call, a webcast replay will be available on MAKO's website, and an audio replay will also be available by calling 800-642-1687 (706-645-9291 for international callers) and entering the passcode 16609765. Both the audio and webcast replays will be available through November 9, 2010.

About MAKO Surgical Corp.

MAKO Surgical Corp. is a medical device company that markets both its RIO® Robotic-Arm Interactive Orthopedic system and its proprietary RESTORIS® implants for minimally invasive orthopedic knee procedures. The MAKO RIO is a surgeon-interactive tactile surgical platform that incorporates a robotic arm and patient-specific visualization technology and prepares the knee joint for the insertion and alignment of MAKO's resurfacing RESTORIS implants through a minimal incision. The FDA-cleared and CE Marked RIO system allows surgeons to provide a precise, consistently reproducible tissue-sparing, bone resurfacing procedure called MAKOplasty® to a large, yet underserved patient population suffering from early to mid-stage osteoarthritic knee disease. MAKO has an intellectual property portfolio of more than 250 owned or licensed patents and patent applications relating to the areas of robotics, haptics, computer assisted surgery and implants. Additional information can be found at .

CONTACT: MAKO Surgical Corp. Investors: Susan M. Verde 954-927-2044 x349 sverde@makosurgical.com Westwicke Partners Mark Klausner 443-213-0500 mark.klausner@westwicke.com